Literature DB >> 9248773

Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate.

K H Schreeb, S Freudenthaler, S V Vormfelde, U Gundert-Remy, C H Gleiter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9248773

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  12 in total

1.  Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence.

Authors:  Ann M Manzardo; Jianghua He; Albert Poje; Elizabeth C Penick; Jan Campbell; Merlin G Butler
Journal:  Drug Alcohol Depend       Date:  2013-08-11       Impact factor: 4.492

2.  Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages.

Authors:  Mohammad Shoeb; Kota V Ramana
Journal:  Free Radic Biol Med       Date:  2011-10-24       Impact factor: 7.376

3.  Change in psychiatric symptomatology after benfotiamine treatment in males is related to lifetime alcoholism severity.

Authors:  Ann M Manzardo; Tiffany Pendleton; Albert Poje; Elizabeth C Penick; Merlin G Butler
Journal:  Drug Alcohol Depend       Date:  2015-04-08       Impact factor: 4.492

4.  High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats.

Authors:  R Babaei-Jadidi; N Karachalias; C Kupich; N Ahmed; P J Thornalley
Journal:  Diabetologia       Date:  2004-12-11       Impact factor: 10.122

5.  Effect of thiamine administration on metabolic profile, cytokines and inflammatory markers in drug-naïve patients with type 2 diabetes.

Authors:  Manuel González-Ortiz; Esperanza Martínez-Abundis; José A Robles-Cervantes; Viridiana Ramírez-Ramírez; Maria G Ramos-Zavala
Journal:  Eur J Nutr       Date:  2010-07-21       Impact factor: 5.614

6.  A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy.

Authors:  Alaa Alkhalaf; Astrid Klooster; Willem van Oeveren; Ulrike Achenbach; Nanne Kleefstra; Robbert J Slingerland; G Sophie Mijnhout; Henk J G Bilo; Reinold O B Gans; Gerjan J Navis; Stephan J L Bakker
Journal:  Diabetes Care       Date:  2010-04-22       Impact factor: 17.152

Review 7.  Vitamin B1 (thiamine) and dementia.

Authors:  Gary E Gibson; Joseph A Hirsch; Pasquale Fonzetti; Barry D Jordan; Rosanna T Cirio; Jessica Elder
Journal:  Ann N Y Acad Sci       Date:  2016-03-11       Impact factor: 5.691

8.  The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial.

Authors:  David A Fraser; Lien M Diep; Inger Anette Hovden; Kristian B Nilsen; Kari Anne Sveen; Ingebjørg Seljeflot; Kristian F Hanssen
Journal:  Diabetes Care       Date:  2012-03-23       Impact factor: 19.112

9.  Benfotiamine counteracts smoking-induced vascular dysfunction in healthy smokers.

Authors:  Alin Stirban; Simona Nandrean; Stanley Kirana; Christian Götting; Ioan Andrei Veresiu; Diethelm Tschoepe
Journal:  Int J Vasc Med       Date:  2012-10-03

10.  Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.

Authors:  Marie-Laure Volvert; Sandrine Seyen; Marie Piette; Brigitte Evrard; Marjorie Gangolf; Jean-Christophe Plumier; Lucien Bettendorff
Journal:  BMC Pharmacol       Date:  2008-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.